These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2862703)

  • 21. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of low doses of captopril, alone or associated with diuretics, in the treatment of mild and moderate hypertension].
    Hatab SA; dos Santos AG
    Arq Bras Cardiol; 1984 Apr; 42(4):305-9. PubMed ID: 6391437
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term effects of endralazine (BQ-22-708) in patients with renal impairment and hypertension.
    Kingswood JC; Harrison PR; Banks RA; Higgs E; Mackenzie JC
    Postgrad Med J; 1983; 59 Suppl 3():173-6. PubMed ID: 6647204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].
    Zech PY; Trotta P; Labeeuw M
    Nouv Presse Med; 1981 Apr; 10(19):1571-4. PubMed ID: 7025847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta blockade during captopril treatment for hypertension.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    N Engl J Med; 1980 Nov; 303(19):1121-2. PubMed ID: 6106894
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined treatment with minoxidil and captopril in refractory hypertension.
    Traub YM; Levey BA
    Arch Intern Med; 1983 Jun; 143(6):1142-4. PubMed ID: 6344825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive drug management of hypertension.
    Oparil S; Winternitz S
    Cardiovasc Clin; 1984; 14(3):73-91. PubMed ID: 6144392
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
    Elliott HL; Meredith PA; Howden CW; Lawrie CB; Reid JL
    Int J Clin Pharmacol Res; 1984; 4(1):61-9. PubMed ID: 6469433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of hypertension in children].
    Brandis M
    Monatsschr Kinderheilkd; 1983 Dec; 131(12):833-6. PubMed ID: 6141523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.
    Elliott HL; McLean K; Sumner DJ; Donnelly RJ; Reid JL
    Clin Exp Hypertens A; 1982; 4(8):1409-18. PubMed ID: 6749347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of hypertension: 1980.
    Hall WD
    J Med Assoc Ga; 1980 Sep; 69(9):745-8. PubMed ID: 6106659
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacodynamic and pharmacokinetic studies with the vasodilator endralazine.
    Elliott HL; Meredith PA; Reid JL
    J Hypertens Suppl; 1984 Dec; 2(3):S551-4. PubMed ID: 6599716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension].
    Savioli RM; Lima EV; Estrella LA; Puppi EJ; Praxedes JN; Nassif M; Stoeber GH; Del Nero Júnior E
    Arq Bras Cardiol; 1984 Jan; 42(1):67-71. PubMed ID: 6378150
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of captopril in severe hypertension (author's transl)].
    Elkik F; Monteiro A; Corvol P; Milliez P
    Nouv Presse Med; 1981 Apr; 10(19):1557-63. PubMed ID: 7025845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of captopril in low doses, alone or combined with diuretics, in the treatment of mild or moderate arterial hypertension].
    Dias GC
    Arq Bras Cardiol; 1984 Aug; 43(2):135-7. PubMed ID: 6398043
    [No Abstract]   [Full Text] [Related]  

  • 38. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Captopril in the therapy of resistant hypertension. A multicenter study].
    Mion Júnior D; Silva HB; Marcondes M
    Arq Bras Cardiol; 1983 May; 40(5):363-7. PubMed ID: 6360101
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of severe arterial hypertension with captopril].
    Kohlmann Junior O; Alves Filho G; Figueiredo JF; Marson O; de Almeida FA; Ribeiro AB
    AMB Rev Assoc Med Bras; 1980 Jul; 26(7):223-5. PubMed ID: 7008095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.